Skip to content

13F-HR filed by Redmile Group, LLC

Redmile Group, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:15:25 UTC, with 44 holding rows worth $1,366,251,642.

Accession
0000905148-26-004923
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 44 entries on the cover page, a total value of $1,366,251,642 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,366,251,642 with VALUE read as dollars as filed, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NURIX THERAPEUTICS INC67080M103COMMON STOCK7,901,085$187,334,725dollars as filed
KRYSTAL BIOTECH INC COM501147102Stock527,684$175,486,591dollars as filed
SCHOLAR ROCK HLDG CORP80706P103COM3,033,962$146,601,044dollars as filed
STOKE THERAPEUTICS INC86150R107COM3,869,028$100,594,728dollars as filed
IMMUNOME INC45257U108COM4,363,064$93,849,507dollars as filed
ABSCI CORPORATION00091E109COM6,671,377$71,850,730dollars as filed
Electra Therapeutics, Inc.284825106Common Stock, $0.0001 par value per share5,430,918$61,097,828dollars as filed
ANNEXON INC03589W102COM14,278,075$60,396,257dollars as filed
NEUROGENE INC64135M105COMMON STOCK1,562,199$43,460,376dollars as filed
REGENXBIO INC75901B107COM5,048,502$38,015,220dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK5,086,990$34,693,272dollars as filed
FATE THERAPEUTICS INC31189P102COM12,872,946$30,508,882dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS2,460,894$26,897,571dollars as filed
BEAM THERAPEUTICS INC07373V105COM1,061,782$25,960,570dollars as filed
ATTOVIA THERAPEUTICS INC04987L102COM1,163,587$19,943,881dollars as filed
AGOMAB THERAPEUTICS NV00860C102SPONSORED ADS1,740,230$19,316,553dollars as filed
NUVATION BIO INC COM CL A67080N101Stock3,031,009$16,973,650dollars as filed
ADARx Pharmaceuticals, Inc.00654F105Common Stock, par value $0.0001 per share769,345$15,340,739dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock381,319$14,650,276dollars as filed
ADC THERAPEUTICS SAH0036K147COMMON STOCK11,584,552$14,133,153dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK1,944,342$14,057,593dollars as filed
ZYMEWORKS INC98985Y108COM491,654$13,023,914dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share833,157$11,439,246dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM189,538$11,372,280dollars as filed
CLIMB BIO INC28658R106COMMON STOCK974,489$11,177,389dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW321,770$10,428,566dollars as filed
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK7,185,263$9,987,516dollars as filed
AURA BIOSCIENCES INC05153U107COMMON STOCK1,552,479$9,749,568dollars as filed
COGENT BIOSCIENCES INC19240Q201COM296,606$9,497,324dollars as filed
CERIBELL INC15678C102COMMON STOCK386,786$9,433,711dollars as filed
Odyssey Therapeutics, Inc.67613T104COMMON STOCK374,510$8,321,612dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock191,036$7,104,629dollars as filed
LIVANOVA PLCG5509L101SHS84,132$6,436,098dollars as filed
ATARA BIOTHERAPEUTICS INC046513206COM NEW636,852$5,413,242dollars as filed
INSMED INC COM PAR $.01457669307Stock42,902$4,896,834dollars as filed
EUPRAXIA PHARMACEUTICALS INC29842P105COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1519,881$4,730,917dollars as filed
DBV TECHNOLOGIES S A23306J309SPONSORED ADS373,417$4,391,384dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM292,817$3,944,245dollars as filed
TCGX ACQUISITION CORPG8708J109COM299,860$3,751,249dollars as filed
PRIME MEDICINE INC74168J101COM1,146,860$3,503,657dollars as filed
INVIVYD INC00534A102COMMON STOCK2,285,320$1,988,457dollars as filed
OCULAR THERAPEUTIX INC67576A100COM243,954$1,871,127dollars as filed
ARDELYX INC039697107COM523,870$1,791,635dollars as filed
PLIANT THERAPEUTICS INC729139105COM772,126$833,896dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000905148-26-004923this filing2026-11-16